THYROID CANCER2008 - 2012
JOHNS HOPKINS HOSPITALCANCER REGISTRY
Prepared by Theresa SanLorenzo-Caswell, CTR09/02/2013
HEAD/NECK OF THE SKINANALYTIC vs. NON-ANALYTIC by YEARN = 1800
2008 2009 2010 2011 2012
ANALYTIC (1381) 207 243 295 294 340
NON-ANALYTIC (182) 37 40 40 34 32
25
75
125
175
225
275
325
375
NU
MBE
R
THYROID CANCER2008-2012 ALL CASES = 1562ANALYTIC vs. NON-ANALYTIC
HEAD/NECK OF THE SKINAGE AT DIAGNOSIS, ALL CASESN = 1800
0 - 19 20 - 29 30 - 39 40 - 49 50 - 59 60 - 69 70 - 79 80+
MALE (431) 7 27 55 80 116 105 34 7
FEMALE (1130) 32 126 258 275 230 136 60 14
25
75
125
175
225
NU
MBE
RTHYROID CANCER2008-2012 ALL CASES = 1562 AGE AT DIAGNOSIS BY GENDER
THYROID CANCER2008-2012 ALL CASES = 1562GENDER BY YEAR
2008 2009 2010 2011 2012
MALE 64 73 80 105 109
FEMALE 180 210 255 223 263
25
75
125
175
225
275
NU
MBE
R
THYROID CANCER2008-2012 ALL CASES = 1562RACE/ETHNICITY BY GENDER
CAUCASIAN AFRICAN AMERI-CAN
HISPANIC OTHER
MALE 362 26 11 32
FEMALE 851 127 43 110
50
150
250
350
450
550
650
750
850
NU
MBE
R
THYROID CANCER2008-2012 ALL CASES = 1562STATE OF RESIDENCE AT DIAGNOSIS
MD60.3%
VA21.3%
PA6.3%
DE2.2%
WV2.0%
OUT OF COUNTRY1.2%
FL1.1%
NY1.1%
ALL OTHER STATES4.5%
THYROID CANCER2008-2012 ALL MARYLAND CASES = 942COUNTY OF RESIDENCE AT DIAGNOSIS
BALTIMORE CO.15.1%
MONTGOMERY CO.12.6%
BALTIMORE CITY12.0%
HOWARD CO.11.2%
ANNE ARUNDEL CO.10.9%
FREDERICK CO.10.0%
PRINCE GEORGES CO.4.9%
HARFORD CO.4.5%
ALL OTHER COUNTIES18.9%
THYROID CANCER2008-2012 ALL CASES = 1562BY HISTOLOGY
PAPILLARY CA91.6%
MEDULLARY CA3.4%
FOLLICULAR CA1.9% ALL OTHER HISTOLOGIES
3.2%
THYROID CANCER2008-2012 ALL ANALTYIC CASES = 1365AJCC STAGE BY GENDER
AJCC I AJCC II AJCC III AJCC IV AJCC UNK
MALE 228 28 55 51 2
FEMALE 809 36 85 70 1
50
150
250
350
450
550
650
750
850
NU
MBE
R
Excludes class 0: Diagnosed at JHH only; all treatment elsewhere
THYROID CANCER2008-2012 ANALYTIC CASES = 1365*AJCC STAGE
AJCC I75.9%
AJCC II4.8%
AJCC III10.2%
AJCC IV8.9% AJCC UNK
0.2%
*Excludes class 0: Diagnosed at JHH only; all treatment elsewhere
THYROID CANCER2008-2012 ANALYTIC CASES* TREATMENT BY STAGE
AJCC I (1037) AJCC II (64) AJCC III (140) AJCC IV (121)
Surgery 9.8 1.5 1.4 2.4
Radiation 0 1.5 0 3.3
Surgery & Radiation 0.7 0 0.7 0.8
Surgery & Hormone 63.3 53.1 32.9 16.5
Surgery, Radiation & Hormone 25.8 43.9 65.0 60.6
All Other Combinations 0.1 0 0 14.8
Not Treated 0.3 0 0 1.6
100% 100% 100% 100%
*Excludes class 0: Diagnosed at JHH only; all treatment elsewhere
THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB
YR 0 YR 1 YR 2 YR 3 YR 4 YR 5
JHH (357) 1 0.9916 0.9775 0.9746 0.9718 0.9689
SEER (14645) 1 0.996 0.993 0.989 0.984 0.98
NCDB (49319) 1 0.997 0.993 0.989 0.985 0.981
75%
85%
95%
AJCC I
PERC
ENTA
GE
©2013 NCDB, CoC©SEER; SEER*STAT
THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB
YR 0 YR 1 YR 2 YR 3 YR 4 YR 5
JHH (37) 1 1 1 1 0.9722 0.9722
SEER (1811) 1 0.991 0.981 0.973 0.961 0.948
NCDB (7122) 1 0.993 0.986 0.979 0.968 0.957
93%
94%
95%
96%
97%
98%
99%
100%
AJCC II
PERC
ENTA
GE
©2013 NCDB, CoC©SEER; SEER*STAT
THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB
YR 0 YR 1 YR 2 YR 3 YR 4 YR 5
JHH (71) 1 1 1 0.9714 0.9714 0.9714
SEER (2169) 1 0.987 0.975 0.963 0.944 0.93
NCDB (8179) 1 0.983 0.972 0.957 0.941 0.927
89%
91%
93%
95%
97%
99%
AJCC III
PERC
ENTA
GE
©2013 NCDB, CoC©SEER; SEER*STAT
THYROID CANCER 5-YEAR OBSERVED SURVIVAL2003-2006JHH vs. SEER vs. NCDB
YR 0 YR 1 YR 2 YR 3 YR 4 YR 5
JHH (51) 1 0.7059 0.6657 0.6078 0.5294 0.5098
SEER (1762) 1 0.761 0.699 0.66 0.623 0.596
NCDB (5885) 1 0.776 0.714 0.672 0.635 0.598
5%15%25%35%45%55%65%75%85%95%
AJCC IV
PERC
ENTA
GE
©2013 NCDB, CoC©SEER; SEER*STAT
Top Related